Confronting antifungal resistance, tolerance, and persistence: advances in drug target discovery and delivery systems
Abstract
Human pathogenic fungi pose a serious threat to human health and safety. Unfortunately, the limited number of antifungal options is exacerbated by the continuous emergence of drug-resistant variants, leading to frequent drug treatment failures. Recent studies have also highlighted the clinical importance of other modes of fungal survival of antifungal treatment, including drug tolerance and persistence, pointing to the complexity of the fungal response to antifungal drugs. A lack of understanding of the fungal drug response has hampered the identification of new targets, the development of alternative antifungal strategies and the design of appropriate delivery systems. In this review we summarize recent advances in the study of antifungal resistance, tolerance and persistence, with an emphasis on promising drug targets and drug delivery systems that may yield important insights into the development of new or improved antifungal therapies against fungal infections.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Biofilm formation helps fungal cells survive antifungal treatment by secreting extracellular matrix and enhancing drug efflux pump activity, which is closely related to antifungal tolerance and resistance.
“Biofilm formation helps fungal cells survive antifungal treatment by secreting extracellular matrix and enhancing drug efflux pump activity, which is closely related to antifungal tolerance and resistance [75–77].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [77]
The citation lists haven’t been fetched yet
References 160 · Cited by 63
- Authors
- Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L.
- Affiliations
- Chinese Academy of Sciences (CN)
- Hebei University (CN)
- Guangxi Academy of Sciences (CN)
- Weifang Medical University (CN)
- Corresponding author
- Wang, Yiting
- Xue, Xinying
- Wang, Linqi
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 200
- Pages
- 115007
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4384120134
- Cited by
- 63
- References
- 160
- Citations by year
- 2026: 20 · 2025: 22 · 2024: 16 · 2023: 4
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Keywords
- antifungal resistance, antifungal tolerance, fungal persistence, drug target identification, drug delivery systems, human pathogenic fungi, fungal infection, antifungal therapy
- MeSH terms
- Antifungal Agents, Drug Tolerance, Fungi, Humans, Mycoses, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review